Literature DB >> 11153446

Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone.

F S Chow1, A Sharma, W J Jusko.   

Abstract

A physiologic pharmacodynamic model was developed to jointly characterize the effects of corticosteroid treatment on adrenal suppression and T-helper cell trafficking during single and multiple dosing in asthmatic patients. Methylprednisolone (MP), cortisol, and T-helper cell concentrations obtained from a previously published study during single day and 6 days of multiple dosing MP treatment were examined. The formation and disposition kinetics of MP were described with a compartmental model. The biorhythmic profile of basal cortisol secretion rate was analyzed using a recent Fourier approach based on circadian harmonics. A three-compartment loop model was proposed to represent three major T-helper cell pools: blood, extravascular site, and lymph nodes. T-helper cell synthesis and degradation rate constants were obtained from the literature. The suppressive effects of cortisol and MP on T-helper cell concentrations were described with a joint additive inhibition function altering the cell migration rate from lymph nodes to blood. The model adequately described both plasma cortisol profiles and T-helper cells in blood after single and multiple doses of MP. The potency of MP for suppression of cortisol secretion was estimated as IC50 = 0.8 ng/ml. The biorhythmic nature of the basal T-helper cells in blood was well described as under the influence of basal circadian cortisol concentrations with IC50 = 79 ng/ml. The model fitted potency of MP for suppression of T-helper cells was IC50 = 4.6 ng/ml. The observed rebound of T-helper cells in blood can also be described by the proposed model. The rhythm and suppression of plasma cortisol and T-helper cells before and during single and multiple dose MP treatment were adequately described by these extended indirect response models.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11153446     DOI: 10.1023/a:1020974408657

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  31 in total

1.  Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.

Authors:  K L Slayter; E A Ludwig; K H Lew; E Middleton; J J Ferry; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1996-03       Impact factor: 6.875

2.  Turnover rate of normal blood lymphocytes and exchangeable pool size in man, calculated from analysis of chromosomal aberrations sustained during extracorporeal irradiation of the blood.

Authors:  E O Field; H B Sharpe; K B Dawson; V Andersen; S A Killmann; E Weeke
Journal:  Blood       Date:  1972-01       Impact factor: 22.113

Review 3.  The traffic of lymphocytes.

Authors:  W L Ford; J L Gowans
Journal:  Semin Hematol       Date:  1969-01       Impact factor: 3.851

4.  Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking.

Authors:  M A Milad; E A Ludwig; S Anné; E Middleton; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1994-12

5.  A program package for simulation and parameter estimation in pharmacokinetic systems.

Authors:  D Z D'Argenio; A Schumitzky
Journal:  Comput Programs Biomed       Date:  1979-03

6.  Circadian changes of T lymphocyte subsets in human peripheral blood.

Authors:  T Miyawaki; K Taga; T Nagaoki; H Seki; Y Suzuki; N Taniguchi
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

7.  Dynamic modeling of cortisol reduction after inhaled administration of fluticasone propionate.

Authors:  S Rohatagi; A Bye; C Falcoz; A E Mackie; B Meibohm; H Möllmann; H Derendorf
Journal:  J Clin Pharmacol       Date:  1996-10       Impact factor: 3.126

8.  Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans.

Authors:  M Hellerstein; M B Hanley; D Cesar; S Siler; C Papageorgopoulos; E Wieder; D Schmidt; R Hoh; R Neese; D Macallan; S Deeks; J M McCune
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

9.  Pharmacoimmunodynamics of methylprednisolone: trafficking of helper T lymphocytes.

Authors:  L E Fisher; E A Ludwig; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1992-08

10.  Subsets of blood, spleen and recirculating lymphocytes in man.

Authors:  G Reinecke; R Pabst
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

View more
  7 in total

1.  A stochastic version of corticosteriod pharmacogenomic model.

Authors:  Xiaohong Qi
Journal:  AAPS J       Date:  2005-06-23       Impact factor: 4.009

Review 2.  Pharmacokinetic/pharmacodynamic modeling in inflammation.

Authors:  Hoi-Kei Lon; Dongyang Liu; William J Jusko
Journal:  Crit Rev Biomed Eng       Date:  2012

Review 3.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

4.  Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation.

Authors:  Mindy He Magee; Robert A Blum; Christian D Lates; William J Jusko
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

Review 5.  Chronopharmacology of glucocorticoids.

Authors:  Megerle L Scherholz; Naomi Schlesinger; Ioannis P Androulakis
Journal:  Adv Drug Deliv Rev       Date:  2019-02-21       Impact factor: 15.470

Review 6.  Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.

Authors:  David Czock; Frieder Keller; Franz Maximilian Rasche; Ulla Häussler
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

7.  Pharmacodynamics of glucose regulation by methylprednisolone. II. normal rats.

Authors:  Jin Y Jin; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2009-01       Impact factor: 1.627

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.